Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of combretastatin A4 and its prodrugs as an immune enhancing therapy

Use of combretastatin A4 and its prodrugs as an immune enhancing therapy

US Patent 6773702 · Granted Aug 10, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Folate receptor targeted nanoparticle drug conjugates and uses thereof2024
Folate receptor targeted nanoparticle drug conjugates and uses thereof2023
Tricyclic compounds as anticancer agents2018
Methods of inducing indolamine 2,3—dioxygenase (IDO)2017
Tricyclic compounds as anticancer agents2017
Methods and antibodies for treating cancer2017
Combination therapy for the treatment of proliferative diseases2016
Tricyclic compounds as anticancer agents2016
Method of treating rash in patients undergoing anti-EGFR therapy2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof2016
Functionalized stilbene derivatives as improved vascular targeting agents2016
Functionalized stilbene derivatives as improved vascular targeting agents2015